股票代码：******
网站地图
On August 21, the 2022 Seminar on Resilient Urban Development and Scientific and Technological Emergencies, hosted by the School of Innovation and Entrepreneurship of Southern University of Science and Technology and the Institute of Risk Analysis, Prediction and Control, organized by Jiangxi Institute of Biological Products Co. and directed by the China Earthquake Emergency Search and Rescue Center of the Ministry of Emergency Management and Shenzhen Emergency Bureau, was held at the Shenzhen Talent Training Institute.
Provincial Market Supervision Bureau leaders visited our company for research and guidance
On July 7, the provincial market supervision bureau party secretary, director Xie Laifa, deputy director Tan Wenying and a dozen other people visited our company to carry out inspection and research. Liu Zhibin, vice mayor of the municipal government, accompanied the visit. Yao Xiaodong, general manager of the company, led all the staff to receive them warmly.
Jiangxi Biology Postdoctoral Innovation Practice Base was awarded
On the morning of June 23, the provincial postdoctoral work conference and training course for postdoctoral managers sponsored by the provincial Department of Human Resources and Social Security was held in Jinxi Hotel in Nanchang. Our company participated in the meeting as one of the 30 enterprises approved to build provincial postdoctoral innovation practice base in 2022.
Our leaders study the spirit of the provincial drug production supervision meeting in depth
On May 20, the Provincial Drug Administration held a video conference on the supervision of drug production in the province. Provincial Drug Administration Supervision Bureau party members, deputy director Zhang Guangwen and other leaders attended this meeting, our general manager Yao Xiaodong led the company's quality responsible, production responsible and quality, production, pharmacovigilance and other departments through the remote video conference form the whole meeting, and carefully record the contents of the meeting.
Product Center
2.5ml,10000IU/ branch
1. This product is a liquid product. The product should not be used if it is cloudy, has precipitates that cannot be shaken, foreign bodies, cracks in the ampoule, unclear labels, or expired. Detailed records should be kept for each injection, including name, sex, age, address, number of injections, reaction after the last injection, results of the allergy test and reaction after the injection, name and batch number of the antitoxin used, etc. 3. Injection equipment and injection site should be strictly disinfected. Syringes should be used exclusively, and if not, they should be thoroughly washed and sterilized after use, preferably by dry baking or autoclaving, and syringes should be separated when injecting toxoid. 4. Special attention should be paid to the prevention of allergic reactions when using antitoxin. Allergy tests must be done before injection and a detailed history of previous allergies must be asked. Anyone who has a history of bronchial asthma, cushings fever, eczema or angioneurotic edema, or who is allergic to a substance, or who has been injected with equine serum preparations in the past, must be especially careful about the occurrence of allergic reactions.
0.75ml,1500IU/ branch
1. This product is a liquid product. The product should not be used if it is cloudy, has precipitates that cannot be shaken, foreign bodies, cracks in the ampoule, unclear labels, or expired. Detailed records should be kept for each injection, including name, sex, age, address, number of injections, reaction after the last injection, results of the allergy test and reaction after the injection, name and batch number of the antitoxin used, etc. 3. Injection equipment and injection site should be strictly disinfected. Syringes should be used exclusively, and if not, they should be thoroughly washed and sterilized after use, preferably by dry baking or autoclaving, and syringes should be separated when injecting toxoid. 4. Special attention should be paid to the prevention of allergic reactions when using antitoxin. Allergy tests must be done before injection and a detailed history of previous allergies must be asked. Anyone who has a history of bronchial asthma, cushings fever, eczema or angioneurotic edema, or who is allergic to a substance, or who has been injected with equine serum preparations in the past, must be especially careful about the occurrence of allergic reactions.
Business Map
Note: The map is only used to show the business situation and does not represent any position
Production technology
The company has a modern, automated and GMP compliant biopharmaceutical production workshop, which strictly follows the GMP standard to standardize each step of the production process. While continuously introducing advanced technologies, processes, production and testing equipment at home and abroad to improve production efficiency, we have always adhered to the original intention and mission of "making high-quality drugs for the global people" and established a sound production and quality management system. Be a practitioner of caring for health and ensuring drug safety!
Comprehensive quality management system
Full process risk control guarantee system
Full intelligent high-quality production system
About us
Jiangxi Institute of Biological Products Co., Ltd., founded in 1969, was originally the Jiangxi Branch of Shanghai Institute of Biological Products, Ministry of Health, with a history of nearly 50 years of biopharmaceutics. In 2002, it was transformed into a limited liability company. In December 2017, it implemented shareholding reform. The company has six wholly-owned subsidiaries distributed in the east, west, north and south of China. It is currently a national high-tech leading enterprise specializing in the research, production and sales of antitoxin and immune serum biological products in China. The company has built the first biopharmaceutical production workshop in the field of antiserum, which is aseptic sealed with isolators and complies with GMP standards;
High tech enterprises
Industry leading enterprises
Own proprietary patented technology
More than 50 years of pharmaceutical experience
The products are exported to more than 30 countries and regions
R&D innovation
The company is well aware that R&D innovation is the basis for the enterprise to seek development. For more than 50 years, the company has attached great importance to the construction of R&D work. Through the continuous introduction of talents, we have built a research team led by postdoctoral researchers The company has also cooperated with more than ten famous colleges and universities to become a post doctoral innovation practice base in Jiangxi Province, and many scientific research projects are being promoted in an orderly manner.
Projects under research
Anti snake venom serum project
Anti rabies serum research project
COVID-19 Antiserum Research Project
Other projects under research
Laboratory&Equipment
Total Organic Carbon Analyzer
Atomic Absorber
Liquid Chromatograph
Microspectrophotometer
Particle detector
Corporate culture
Industrial cluster
Hainan Pharmaceutical Research Institute Co., Ltd
Formerly known as Hainan Pharmaceutical Research Institute, Hainan is the only provincial pharmaceutical research institution. It mainly undertakes the R&D, testing and pilot test services of drugs, medical devices, cosmetics and food (health food).
Chifeng Bowen Pharmaceutical Co., Ltd
A scientific and technological manufacturing enterprise mainly engaged in biological and chemical pharmaceuticals, mainly producing animal reproduction drug series mainly composed of tetanus antitoxin antibody serum and pregnant horse serum gonadotropin.
Gaotai Tianhong Biochemical Technology Development Co., Ltd
A high-tech private enterprise integrating the production and sales of horse breeding, biological medicine immune horse serum, pregnant horse serum, etc.
Learn more
Jiangsheng (Shenzhen) Biotechnology Research and Development Center Co., Ltd
Research fields include immunology (including research on immune mechanism), vaccinology, glycobiology, glycosomics, proteomics, genetic engineering, molecular synthesis, human genomics, etc.
Learn more
Add:
Jinggangshan Economic and Technological Development Zone, Ji'an, Jiangxi, P.R.China.
Telephone:
Email:
Pharmacovigilance collection mailbox:
Pharmacovigilance telephone:
Microofficial website
0796-8403905
E-mail 